Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status

por Schlicher, Lisa, Green, Luke G., Romagnani, Andrea, Renner, Florian
Publicado 2023

In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P(1)) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Sele...

por Schlicher, Lisa, Kulig, Paulina, von Münchow, Audrey, Murphy, Mark J., Keller, Marcel P.
Publicado 2022

Requirement of GSK-3 for PUMA induction upon loss of pro-survival PI3K signaling

por Schubert, Florian, Rapp, Juliane, Brauns-Schubert, Prisca, Schlicher, Lisa, Stock, Kerstin, Wissler, Manuela, Weiß, Martina, Charvet, Céline, Borner, Christoph, Maurer, Ulrich
Publicado 2018

Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains

por Elliott, Paul R., Leske, Derek, Wagstaff, Jane, Schlicher, Lisa, Berridge, Georgina, Maslen, Sarah, Timmermann, Frederik, Ma, Biao, Fischer, Roman, Freund, Stefan M.V., Komander, David, Gyrd-Hansen, Mads
Publicado 2021

Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling

por Hrdinka, Matous, Schlicher, Lisa, Dai, Bing, Pinkas, Daniel M, Bufton, Joshua C, Picaud, Sarah, Ward, Jennifer A, Rogers, Catherine, Suebsuwong, Chalada, Nikhar, Sameer, Cuny, Gregory D, Huber, Kilian VM, Filippakopoulos, Panagis, Bullock, Alex N, Degterev, Alexei, Gyrd‐Hansen, Mads
Publicado 2018